Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...

High-dose gold nanoparticle treatment outperformed orlistat in reversing obesity-related damage in rats, according to ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...

Allowing such medications as options could lead to significant savings from improved health, writes Kelley Koch.

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new ...

Discover how small biotechs are innovating in the weight loss therapy market with new treatments targeting unique mechanisms ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...